| __timestamp | Jazz Pharmaceuticals plc | Novartis AG |
|---|---|---|
| Wednesday, January 1, 2014 | 406114000 | 14993000000 |
| Thursday, January 1, 2015 | 449119000 | 14247000000 |
| Friday, January 1, 2016 | 502892000 | 14192000000 |
| Sunday, January 1, 2017 | 544156000 | 14997000000 |
| Monday, January 1, 2018 | 683530000 | 16471000000 |
| Tuesday, January 1, 2019 | 736942000 | 14369000000 |
| Wednesday, January 1, 2020 | 854233000 | 14197000000 |
| Friday, January 1, 2021 | 1451683000 | 14886000000 |
| Saturday, January 1, 2022 | 1416967000 | 14253000000 |
| Sunday, January 1, 2023 | 1343105000 | 12489000000 |
| Monday, January 1, 2024 | 12566000000 |
Data in motion
In the ever-evolving pharmaceutical landscape, effective cost management is crucial. Over the past decade, Jazz Pharmaceuticals plc and Novartis AG have demonstrated contrasting strategies in managing their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Jazz Pharmaceuticals saw a significant increase in SG&A expenses, peaking in 2021 with a 258% rise from 2014 levels. This growth reflects their aggressive expansion and investment in marketing and administrative capabilities. In contrast, Novartis AG maintained a relatively stable SG&A expenditure, with a slight decline of 17% from its 2014 peak. This stability underscores Novartis's focus on operational efficiency and cost control. As the pharmaceutical industry continues to face challenges, these insights into SG&A management offer valuable lessons in balancing growth with fiscal responsibility.
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Novartis AG
Operational Costs Compared: SG&A Analysis of Novartis AG and Alnylam Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Novartis AG and Biogen Inc.
Research and Development Investment: Novartis AG vs Jazz Pharmaceuticals plc
Novartis AG and Viking Therapeutics, Inc.: SG&A Spending Patterns Compared
Novartis AG or CRISPR Therapeutics AG: Who Manages SG&A Costs Better?
Novartis AG and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Novartis AG and BioCryst Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or Jazz Pharmaceuticals plc
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
BioMarin Pharmaceutical Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Alpine Immune Sciences, Inc.